◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
SANTEN PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 10, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 23.9B 25.1B -- -- -- --
Operating Margin % 100.1% 104.3% -- -- -- --
+Ordinary Income 23.8B 24.1B -- -- -- --
Revenue Growth % -1.0% -- -- -- -- --
Line ItemQ4 2025Nov 10, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 224.3B 236.1B -- -- -- --
Total Assets 409.3B 435.7B 416.5B 426.6B 397.1B 413.1B
Total Liabilities 124.1B 130.3B 116.3B 117.2B 86.1B 98.4B
Total Equity 285.2B 305.4B 300.2B 309.4B 311.0B 314.7B
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...